Human Cytomegalovirus Infection In Pregnant Wom...

Azithromycin Treatment Of Drug Induced Gingival...

Merse Cov In Saudi Arabia

Evaluation Of The Combination Of N-acetylcystei...

Carbapenem-resistant Enterobacteriaceae Co-infe...

0 votes
Acute Myeloid Leukaemia - Therapy - Past, Present And Future
Author: Paul Faduola1, Alan Hakim, Juli Mansnérus, Atsuko Imai, Rob O’neill
Publisher: Internet Medical Publishing
18 pages
One time payment: €6.08
Required subscription: Clinical
Type of publication: Article
DOI: 10.3823/440
Follow this publisher

Share this publication:


This study showed that a detailed understanding of the molecular changes associated with chromosomal and genetic abnormalities is necessary to pilot new therapy design. Although several deregulated proteins and genes have been identified, their diversity among AML patients have made it difficult to identify a single substance that can hit these diverse targets. New agents have shown promise but there remains a huge need to be met for effective and targeted therapies to be successful. 

About the publisher:

iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.

Select a payment method